---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-158321"
form_type: "8-K"
ticker: "IMA"
cik: "0001835579"
company_name: "ImageneBio, Inc."
filed_at: "2024-06-10T23:59:59+00:00"
generated_at: "2026-06-01T05:22:24.944530+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Ikena Oncology shareholders elect directors and ratify auditor at 2024 annual meeting

## Summary
- Owen Hughes elected as Class III director with 22,250,184 votes for, 4,967,774 withheld.
- Mark Manfredi elected as Class III director with 24,738,833 votes for, 2,479,125 withheld.
- Ernst & Young ratified as auditor for FY2024 with 34,421,661 for, 31,819 against, 11,827 abstain.

## SEC filing metadata
- accession: 0001193125-24-158321
- form_type: 8-K
- ticker: IMA
- cik: 0001835579
- company_name: ImageneBio, Inc.
- filed_at: 2024-06-10T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1835579/000119312524158321/0001193125-24-158321-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1835579/000119312524158321/d837508d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-158321
- JSON: https://secwatch.observer/filing/0001193125-24-158321.json
- Plain text: https://secwatch.observer/filing/0001193125-24-158321.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.